药捷安康-B(02617)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02617 药捷安康-B

未开盘 02-02 16:08:04

76.100

-6.550

-7.92%

最高85.700	最低75.850	成交量159.55万
今开85.700	昨收82.650	日振幅11.92%
总市值303.64亿	流通市值231.34亿	总股本3.99亿
成交额1.26亿	换手率0.52%	流通股本3.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"药捷安康-B","latestPrice":76.1,"timestamp":1770019684907,"preClose":82.65,"halted":0,"volume":1595515,"delay":0,"changeRate":-0.07924984875983074,"floatShares":304000000,"shares":399000000,"eps":-0.8096789749925806,"marketStatus":"未开盘","change":-6.55,"latestTime":"02-02 16:08:04","open":85.7,"high":85.7,"low":75.85,"amount":126075124,"amplitude":0.119177,"askPrice":76.1,"askSize":1000,"bidPrice":75.95,"bidSize":1500,"shortable":0,"etf":0,"ttmEps":-0.6985050230471251,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770082200000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":82.65,"openAndCloseTimeList":[[1769995800000,1770004800000],[1770008400000,1770019200000]],"volumeRatio":0.6893383027896299,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02617","defaultTab":"news","newsList":[{"id":"2607875770","title":"药捷安康-B盘中异动 股价大涨5.52%报82.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607875770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607875770?lang=zh_cn&edition=full","pubTime":"2026-01-29 13:15","pubTimestamp":1769663700,"startTime":"0","endTime":"0","summary":"2026年01月29日下午盘13时15分，药捷安康-B股票出现异动，股价快速上涨5.52%。截至发稿，该股报82.200港元/股，成交量71.9万股，换手率0.24%，振幅8.86%。资金方面，该股资金流入2381.45万港元，流出2006.68万港元。药捷安康-B股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，泰格医药、方达控股、药捷安康-B涨幅较大，振幅较大的相关个股有银诺医药-B、中生北控生物科技、维亚生物，振幅分别为19.08%、15.53%、13.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129131500a4632aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129131500a4632aed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2605709614","title":"药捷安康-B01月23日主力净流出226.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2605709614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605709614?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:15","pubTimestamp":1769156148,"startTime":"0","endTime":"0","summary":"01月23日, 药捷安康-B股价跌2.05%，报收83.50元，成交金额1.5亿元，换手率0.58%，振幅5.57%，量比0.69。药捷安康-B今日主力资金净流出226.7万元，上一交易日主力净流入1104.2万元。该股近5个交易日下跌12.51%，主力资金累计净流入506.8万元；近20日主力资金累计净流入1253.0万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162208a6a43839&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123162208a6a43839&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2605463789","title":"药捷安康-B01月21日遭主力抛售161.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605463789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605463789?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:16","pubTimestamp":1768983363,"startTime":"0","endTime":"0","summary":"01月21日, 药捷安康-B股价跌3.96%，报收80.00元，成交金额9654.7万元，换手率0.39%，振幅7.20%，量比0.65。药捷安康-B今日主力资金净流出161.4万元，上一交易日主力净流出209.3万元。该股近5个交易日下跌19.78%，主力资金累计净流入215.3万元；近20日主力资金累计净流入375.5万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121163642a444c220&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121163642a444c220&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1141745006","title":"药捷安康(南京)(02617)更新翌日披露报表，配售2,100,000股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1141745006","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141745006?lang=zh_cn&edition=full","pubTime":"2026-01-20 17:12","pubTimestamp":1768900375,"startTime":"0","endTime":"0","summary":"药捷安康(南京)科技股份有限公司(02617)于2026年1月20日发布翌日披露报表，宣布通过配售方式发行2,100,000股H股，占发行前已发行股本约0.7%。每股发行价为92.85港元。\n本次配售系根据该公司于2025年8月4日股东周年大会的一般授权进行。发行完成后，公司已发行股本由301,666,673股增至303,766,673股，库藏股数目保持不变。公司同时确认，发行事项已遵守相关上市规则和法律法规。\n公告由董事长兼首席执行官吴永谦签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2604163846","title":"港股异动 | 药捷安康-B(02617)再跌超10% 拟配股净筹1.9亿港元 主要用于核心产品研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2604163846","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604163846?lang=zh_cn&edition=full","pubTime":"2026-01-20 11:21","pubTimestamp":1768879300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药捷安康-B(02617)再跌超10%，截至发稿，跌9.02%，报84.7港元，成交额1.17亿港元。消息面上，药捷安康此前宣布，拟配售2100万股新股份，每股配售价92.85港元，较1月13日H股收市价113.2港元折让17.98%，所得款项净额1.9亿港元。其中，60%用于为其核心产品Tinengotinib在中国正在进行单药治疗胆管癌(CCA)的临床试验以及核心产品的其他适应症的研发提供资金；约30%用于其他产品的研发，包括TT-00973、TT-01488及其他分子；约10%用于营运资金及一般企业用途。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1168435089","title":"一周港股牛熊榜 |  次新股也疯狂！智谱飙涨近60%、五一视界飙57.6%、果下科技飙47%、迅策涨39%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168435089","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168435089?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:14","pubTimestamp":1768554878,"startTime":"0","endTime":"0","summary":"1月8日，“全球大模型第一股”智谱AI在港交所挂牌。显示港股市场新股打新潮的火热。该公司是一家致力于克隆地球5.1亿平方公里的科技公司。$挚达科技$ +41.69%周五，挚达科技涨超10%，盘中高见315港元创上市新高。每股作价92.85港元，较1月13日收市价113.2港元折让约17.98%。配售事项预计净集资约1.9亿港元。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"一周港股牛熊榜 |  次新股也疯狂！智谱飙涨近60%、五一视界飙57.6%、果下科技飙47%、迅策涨39%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09961","02513","03317","02386","02650","02208","02655","06808","02617","06651"],"gpt_icon":1},{"id":"2603968699","title":"药捷安康-B盘中异动 早盘股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603968699","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603968699?lang=zh_cn&edition=full","pubTime":"2026-01-16 10:00","pubTimestamp":1768528819,"startTime":"0","endTime":"0","summary":"2026年01月16日早盘10时00分，药捷安康-B股票出现异动，股价急速拉升5.30%。截至发稿，该股报100.300港元/股，成交量41.9544万股，换手率0.14%，振幅5.77%。药捷安康-B股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，药捷安康-B、盛禾生物-B、东曜药业-B涨幅较大，振幅较大的相关个股有奥星生命科技、东曜药业-B、药捷安康-B，振幅分别为8.16%、6.92%、5.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116100019a720c206&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116100019a720c206&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2603656694","title":"药捷安康-B拟折让约17.98%配售210万股，净筹约1.9亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603656694","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603656694?lang=zh_cn&edition=full","pubTime":"2026-01-14 07:13","pubTimestamp":1768345993,"startTime":"0","endTime":"0","summary":"智通财经APP讯，$药捷安康-B $发布公告，于2026年1月13日，公司与配售代理订立配售协议，配售代理将按尽力基准促使承配人按每股配售股份92.85港元的配售价购买210万股配售股份。每股配售股份92.85港元的配售价较股份于2026年1月13日在联交所所报的收市价每股H股113.20港元折让约17.98%。预期配售事项最高所得款项总额及所得款项净额将分别约为1.95亿港元及1.90亿港元。按此基准，净发行价将约为每股配售股份90.54港元。","market":"fut","thumbnail":"https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392489.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"药捷安康-B拟折让约17.98%配售210万股，净筹约1.9亿港元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2603367856","title":"药捷安康-B01月13日主力净流入154.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603367856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603367856?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:16","pubTimestamp":1768292169,"startTime":"0","endTime":"0","summary":"01月13日, 药捷安康-B股价涨0.09%，报收113.20元，成交金额1.8亿元，换手率0.51%，振幅5.75%，量比1.95。药捷安康-B今日主力资金净流入154.2万元，上一交易日主力净流出23.1万元。该股近5个交易日下跌0.96%，主力资金累计净流出192.2万元；近20日主力资金累计净流入71.4万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113162957a714ed7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113162957a714ed7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2603522350","title":"药捷安康-B01月12日主力净流出23.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603522350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603522350?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205750,"startTime":"0","endTime":"0","summary":"01月12日, 药捷安康-B股价跌1.57%，报收113.10元，成交金额8536.2万元，换手率0.25%，振幅5.92%，量比0.87。药捷安康-B今日主力资金净流出23.1万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.25%，主力资金累计净流出107.8万元；近20日主力资金累计净流出82.8万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112162838a4b9bf06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112162838a4b9bf06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2602297563","title":"药捷安康-B(02617)于2026年美国临床肿瘤学会胃肠道肿瘤研讨会公布替恩戈替尼单药治疗晚期胆管癌患者的临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2602297563","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602297563?lang=zh_cn&edition=full","pubTime":"2026-01-12 07:10","pubTimestamp":1768173000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B 发布公告，公司在2026年美国临床肿瘤学会胃肠道肿瘤研讨会上以壁报形式公布了核心产品替恩戈替尼单药治疗晚期胆管癌患者的临床数据。FGFR抑制剂在治疗伴有FGFR2变异的胆管癌中具有已确立的作用。替恩戈替尼作为一种新型FGFR抑制剂，在克服既往FGFR抑制剂获得性耐药方面已显示出有潜力的活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药捷安康-B(02617)于2026年美国临床肿瘤学会胃肠道肿瘤研讨会公布替恩戈替尼单药治疗晚期胆管癌患者的临床数据","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2601287195","title":"药捷安康-B01月07日主力净流出323.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2601287195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601287195?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:15","pubTimestamp":1767773749,"startTime":"0","endTime":"0","summary":"01月07日, 药捷安康-B股价跌1.40%，报收112.80元，成交金额1.0亿元，换手率0.29%，振幅4.37%，量比0.65。药捷安康-B今日主力资金净流出323.2万元，上一交易日主力净流入238.6万元。该股近5个交易日下跌6.78%，主力资金累计净流入93.5万元；近20日主力资金累计净流出59.6万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162047a6fdccd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162047a6fdccd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2595760049","title":"年底了，当初药捷安康纳入指数还没有给说法","url":"https://stock-news.laohu8.com/highlight/detail?id=2595760049","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595760049?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:48","pubTimestamp":1767084480,"startTime":"0","endTime":"0","summary":"　　事情已经过去两三个月了，深证信息公司还是没有给药捷安康纳入指数这事出说明。　　当时药捷安康纳入指数，闹出新闻（图二），有记者采访指数编制方深圳证券信息有限公司，工作人员回复说是正在研究，稍后公司会给回复，新闻报道截图参见图1。　　我们作为投资者相信，国证指数和深证信息公司有自己的担当，会公开直面这个问题，不会淡化处理这个问题。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-12-30/doc-inheqixk7188102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"1102493660","title":"一周港股牛熊榜 | AI材料与有色爆发！中铝国际暴涨20.6%、力勤资源暴涨18.6%、中伟新材大涨16%；因股份解禁，周六福暴跌24.9%、药捷安康暴跌20.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102493660","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102493660?lang=zh_cn&edition=full","pubTime":"2025-12-26 16:46","pubTimestamp":1766738819,"startTime":"0","endTime":"0","summary":"24日镍概念集体走高，力勤资源、中伟新材、新疆新鑫矿业均涨幅近 9%。12月23日，周六福在港交所公告，董事会注意到公司H股价格近期出现不寻常波动。根据数据，此次药捷安康共计5名股东发生解禁，累计解禁股数达977.4万股，占比约2.46%。23日跌超18%、24日继续跌5.8%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02068","03939","HSTECH","06168","06821","02315","02579","02617","HSCEI","HSI","01952","02268","02245"],"gpt_icon":1},{"id":"2594096174","title":"药捷安康-B12月24日遭主力抛售214.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594096174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594096174?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:15","pubTimestamp":1766564119,"startTime":"0","endTime":"0","summary":"12月24日, 药捷安康-B股价跌5.79%，报收130.20元，成交金额8205.8万元，换手率0.20%，振幅10.42%，量比0.43。药捷安康-B今日主力资金净流出214.5万元，上一交易日主力净流出155.4万元。该股近5个交易日下跌23.99%，主力资金累计净流出369.9万元；近20日主力资金累计净流出751.1万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161618a6c96f2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224161618a6c96f2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2593468563","title":"药捷安康-B(02617.HK)跌超14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593468563","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593468563?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:43","pubTimestamp":1766457822,"startTime":"0","endTime":"0","summary":"每经AI快讯，药捷安康-B(02617.HK)跌超14%，截至发稿，跌14.05%，报145港元，成交额1.63亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233599294189.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599294189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2593710995","title":"药捷安康-B盘中异动 下午盘股价大涨5.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593710995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593710995?lang=zh_cn&edition=full","pubTime":"2025-12-22 13:44","pubTimestamp":1766382295,"startTime":"0","endTime":"0","summary":"2025年12月22日下午盘13时44分，药捷安康-B股票出现波动，股价大幅上涨5.55%。截至发稿，该股报173.000港元/股，成交量53.2万股，换手率0.18%，振幅7.75%。药捷安康-B股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，北海康成-B、拨康视云-B、药捷安康-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、华生物-B、加科思-B，振幅分别为23.40%、16.23%、14.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222134456a468f288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222134456a468f288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2592138749","title":"药捷安康-B(02617):替恩戈替尼片新药上市申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2592138749","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592138749?lang=zh_cn&edition=full","pubTime":"2025-12-19 08:21","pubTimestamp":1766103707,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B(02617)发布公告，替恩戈替尼片的新药上市申请已获中国国家药品监督管理局药品审评中心受理，拟用于治疗既往至少接受过一种系统性治疗和FGFR抑制剂治疗的晚期、转移性或不可手术切除的胆管癌成人患者。此前，替恩戈替尼片此适应症已获批准纳入优先审评品种名单及突破性治疗品种名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383441.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药捷安康-B(02617):替恩戈替尼片新药上市申请获国家药品监督管理局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2592634992","title":"药捷安康-B(02617)发表核心产品替恩戈替尼针对胆管癌的探索性临床结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2592634992","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592634992?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:02","pubTimestamp":1765972929,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药捷安康-B 公布，近日，公司核心产品替恩戈替尼在美国开展的针对胆管癌的探索性临床2期结果在《柳叶刀，胃肠病和肝病学》上发表。替恩戈替尼可克服FGFR2融合阳性胆管癌患者对FGFR抑制剂的获得性耐药，并在其他FGFR基因改变的胆管癌患者中显示出抗肿瘤活性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1150760712","title":"港股异动｜生物医药股上扬，药捷安康涨超17%，昭衍新药涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1150760712","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150760712?lang=zh_cn&edition=full","pubTime":"2025-12-17 10:50","pubTimestamp":1765939813,"startTime":"0","endTime":"0","summary":"轩竹生物涨超5%，银诺医药涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"22a0e03e703ab82b83863db78ab69d04","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","02591","02575","06127"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transtherabio.com","stockEarnings":[{"period":"1week","weight":-0.1031},{"period":"1month","weight":-0.3277},{"period":"3month","weight":-0.5796},{"period":"6month","weight":0.7438},{"period":"1year","weight":4.7871},{"period":"ytd","weight":-0.3377}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0166},{"period":"3month","weight":0.0317},{"period":"6month","weight":0.0749},{"period":"1year","weight":0.3239},{"period":"ytd","weight":0.0447}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药捷安康（南京）科技股份有限公司是一家从事生物制药的中国公司，主要专注于发现及开发肿瘤、炎症及心脏代谢疾病小分子创新疗法。该公司的核心产品Tinengotinib是一种处于注册临床阶段的内部发现和开发的MTK抑制剂，适用于某些复发或难治的耐药实体瘤。该公司的肿瘤产品线包括TT-00973（针对 AXL）、TT-01488（用于血液系统恶性肿瘤）、TT-01688（用于炎症性疾病）和 TT-00920（用于慢性心力衰竭）。这些产品能够对多种癌症类型（包括前列腺癌、肝癌、乳腺癌和BTC）产生疗效。它还可用于治疗肝细胞癌、乳腺癌、胆道癌和Pan-FGFR实体瘤。","exchange":"SEHK","name":"药捷安康-B","nameEN":"TRANSTHERA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药捷安康-B(02617)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药捷安康-B(02617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药捷安康-B,02617,药捷安康-B股票,药捷安康-B股票老虎,药捷安康-B股票老虎国际,药捷安康-B行情,药捷安康-B股票行情,药捷安康-B股价,药捷安康-B股市,药捷安康-B股票价格,药捷安康-B股票交易,药捷安康-B股票购买,药捷安康-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药捷安康-B(02617)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药捷安康-B(02617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}